Global Canine Arthritis Treatment

Canine Arthritis Treatment Comprehensive Study by Type (Non-Steroidal Anti-Inflammatory Drugs, Opioids, Stem Cell Therapy), Application (Veterinary Hospitals and Clinics, Retail Pharmacies, Drug Stores, E-commerce), Route of Administration (Oral, Parental, Others), Methods (Surgery, Drugs, Others) Players and Region - Global Market Outlook to 2028

Canine Arthritis Treatment Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Canine arthritis is a condition of pets that leads to inflammation in joints and results in a considerable increase in inflammation because of lack of correct treatment. It usually affects the joints like the knee, elbow, shoulder, hip, and funiculus. There are numerous causes of canine arthritis in dogs like accidental injuries, obesity, and failure in bone development. Among all canine arthritis, arthritis is commonest. One in every 5 adult dogs is littered with arthritis. This rising prevalence of arthritis is making demand for its novel medicine. This is the key issue fuelling the expansion of the global canine arthritis treatment market.This growth is primarily driven by High Prevalence of Canine Obesity and Motion Injuries .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Diseases & Therapeutic Areas sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Nutri-Vet, LLC (United States), Boehringer Ingelheim (Germany), Liquid Health Inc. (United States), American Regent, Inc. (United States), Matsun Nutrition (United States), Synflex America Inc. (United States), Thorne Research Inc. (United States), Vetalogica (Australia) and Elanco (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In May 2019, Elanco announces the UK launch of a new treatment for canine osteoarthritis pain. Galliprant is the first in a class of drugs called piprants, or non-COX-inhibiting prostaglandin receptor antagonists (PRAs), which specifically target the EP4 receptor largely responsible for OA pain and inflammation1,3 without interfering with other prostanoids and receptors, thereby minimizing the impact on gastrointestinal and kidney homeostasis.The increasing adoption of dogs has also increased the market for the treatment. The prevalence is high in animals. The factors like growing cases of arthritis and related disorders, instability in the joints, ligament fracture, long term pain in the joints, excessive rubbing of the joints, increased adoption of canines (dogs), and fast approval for veterinary regenerative medicine are driving the growth of the market.

Influencing Trend:
Increasing Adoption of Dogs

Market Growth Drivers:
High Prevalence of Canine Obesity and Motion Injuries and Increase in Awareness regarding Canine Health

Challenges:
Side Effects Associated with Treatment Errors

Restraints:
High Cost of Treatment

Opportunities:
Increasing Advancement in The Treatment Methods

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Canine Arthritis Treatment Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Canine Arthritis Treatment Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Canine Arthritis Treatment players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Canine Arthritis Treatment Study Sheds Light on
— The Canine Arthritis Treatment Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Canine Arthritis Treatment industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Canine Arthritis Treatment industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Non-Steroidal Anti-Inflammatory Drugs
  • Opioids
  • Stem Cell Therapy
By Application
  • Veterinary Hospitals and Clinics
  • Retail Pharmacies
  • Drug Stores
  • E-commerce
By Route of Administration
  • Oral
  • Parental
  • Others

By Methods
  • Surgery
  • Drugs
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Prevalence of Canine Obesity and Motion Injuries
      • 3.2.2. Increase in Awareness regarding Canine Health
    • 3.3. Market Challenges
      • 3.3.1. Side Effects Associated with Treatment Errors
    • 3.4. Market Trends
      • 3.4.1. Increasing Adoption of Dogs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Canine Arthritis Treatment, by Type, Application, Route of Administration, Methods and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Canine Arthritis Treatment (Value)
      • 5.2.1. Global Canine Arthritis Treatment by: Type (Value)
        • 5.2.1.1. Non-Steroidal Anti-Inflammatory Drugs
        • 5.2.1.2. Opioids
        • 5.2.1.3. Stem Cell Therapy
      • 5.2.2. Global Canine Arthritis Treatment by: Application (Value)
        • 5.2.2.1. Veterinary Hospitals and Clinics
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Drug Stores
        • 5.2.2.4. E-commerce
      • 5.2.3. Global Canine Arthritis Treatment by: Route of Administration (Value)
        • 5.2.3.1. Oral
        • 5.2.3.2. Parental
        • 5.2.3.3. Others
      • 5.2.4. Global Canine Arthritis Treatment by: Methods (Value)
        • 5.2.4.1. Surgery
        • 5.2.4.2. Drugs
        • 5.2.4.3. Others
      • 5.2.5. Global Canine Arthritis Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Canine Arthritis Treatment (Price)
      • 5.3.1. Global Canine Arthritis Treatment by: Type (Price)
  • 6. Canine Arthritis Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Nutri-Vet, LLC (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boehringer Ingelheim (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Liquid Health Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. American Regent, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Matsun Nutrition (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Synflex America Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Thorne Research Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Vetalogica (Australia)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Elanco (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Canine Arthritis Treatment Sale, by Type, Application, Route of Administration, Methods and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Canine Arthritis Treatment (Value)
      • 7.2.1. Global Canine Arthritis Treatment by: Type (Value)
        • 7.2.1.1. Non-Steroidal Anti-Inflammatory Drugs
        • 7.2.1.2. Opioids
        • 7.2.1.3. Stem Cell Therapy
      • 7.2.2. Global Canine Arthritis Treatment by: Application (Value)
        • 7.2.2.1. Veterinary Hospitals and Clinics
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Drug Stores
        • 7.2.2.4. E-commerce
      • 7.2.3. Global Canine Arthritis Treatment by: Route of Administration (Value)
        • 7.2.3.1. Oral
        • 7.2.3.2. Parental
        • 7.2.3.3. Others
      • 7.2.4. Global Canine Arthritis Treatment by: Methods (Value)
        • 7.2.4.1. Surgery
        • 7.2.4.2. Drugs
        • 7.2.4.3. Others
      • 7.2.5. Global Canine Arthritis Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Canine Arthritis Treatment (Price)
      • 7.3.1. Global Canine Arthritis Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Canine Arthritis Treatment: by Type(USD Million)
  • Table 2. Canine Arthritis Treatment Non-Steroidal Anti-Inflammatory Drugs , by Region USD Million (2017-2022)
  • Table 3. Canine Arthritis Treatment Opioids , by Region USD Million (2017-2022)
  • Table 4. Canine Arthritis Treatment Stem Cell Therapy , by Region USD Million (2017-2022)
  • Table 5. Canine Arthritis Treatment: by Application(USD Million)
  • Table 6. Canine Arthritis Treatment Veterinary Hospitals and Clinics , by Region USD Million (2017-2022)
  • Table 7. Canine Arthritis Treatment Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 8. Canine Arthritis Treatment Drug Stores , by Region USD Million (2017-2022)
  • Table 9. Canine Arthritis Treatment E-commerce , by Region USD Million (2017-2022)
  • Table 10. Canine Arthritis Treatment: by Route of Administration(USD Million)
  • Table 11. Canine Arthritis Treatment Oral , by Region USD Million (2017-2022)
  • Table 12. Canine Arthritis Treatment Parental , by Region USD Million (2017-2022)
  • Table 13. Canine Arthritis Treatment Others , by Region USD Million (2017-2022)
  • Table 14. Canine Arthritis Treatment: by Methods(USD Million)
  • Table 15. Canine Arthritis Treatment Surgery , by Region USD Million (2017-2022)
  • Table 16. Canine Arthritis Treatment Drugs , by Region USD Million (2017-2022)
  • Table 17. Canine Arthritis Treatment Others , by Region USD Million (2017-2022)
  • Table 18. South America Canine Arthritis Treatment, by Country USD Million (2017-2022)
  • Table 19. South America Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 20. South America Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 21. South America Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 22. South America Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 23. Brazil Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 24. Brazil Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 25. Brazil Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 26. Brazil Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 27. Argentina Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 28. Argentina Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 29. Argentina Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 30. Argentina Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 31. Rest of South America Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 32. Rest of South America Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 33. Rest of South America Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 34. Rest of South America Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 35. Asia Pacific Canine Arthritis Treatment, by Country USD Million (2017-2022)
  • Table 36. Asia Pacific Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 37. Asia Pacific Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 38. Asia Pacific Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 39. Asia Pacific Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 40. China Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 41. China Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 42. China Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 43. China Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 44. Japan Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 45. Japan Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 46. Japan Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 47. Japan Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 48. India Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 49. India Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 50. India Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 51. India Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 52. South Korea Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 53. South Korea Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 54. South Korea Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 55. South Korea Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 56. Taiwan Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 57. Taiwan Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 58. Taiwan Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 59. Taiwan Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 60. Australia Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 61. Australia Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 62. Australia Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 63. Australia Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 68. Europe Canine Arthritis Treatment, by Country USD Million (2017-2022)
  • Table 69. Europe Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 70. Europe Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 71. Europe Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 72. Europe Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 73. Germany Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 74. Germany Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 75. Germany Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 76. Germany Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 77. France Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 78. France Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 79. France Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 80. France Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 81. Italy Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 82. Italy Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 83. Italy Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 84. Italy Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 85. United Kingdom Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 86. United Kingdom Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 87. United Kingdom Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 88. United Kingdom Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 89. Netherlands Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 90. Netherlands Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 91. Netherlands Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 92. Netherlands Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 93. Rest of Europe Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 94. Rest of Europe Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 95. Rest of Europe Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 96. Rest of Europe Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 97. MEA Canine Arthritis Treatment, by Country USD Million (2017-2022)
  • Table 98. MEA Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 99. MEA Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 100. MEA Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 101. MEA Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 102. Middle East Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 103. Middle East Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 104. Middle East Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 105. Middle East Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 106. Africa Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 107. Africa Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 108. Africa Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 109. Africa Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 110. North America Canine Arthritis Treatment, by Country USD Million (2017-2022)
  • Table 111. North America Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 112. North America Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 113. North America Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 114. North America Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 115. United States Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 116. United States Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 117. United States Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 118. United States Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 119. Canada Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 120. Canada Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 121. Canada Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 122. Canada Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 123. Mexico Canine Arthritis Treatment, by Type USD Million (2017-2022)
  • Table 124. Mexico Canine Arthritis Treatment, by Application USD Million (2017-2022)
  • Table 125. Mexico Canine Arthritis Treatment, by Route of Administration USD Million (2017-2022)
  • Table 126. Mexico Canine Arthritis Treatment, by Methods USD Million (2017-2022)
  • Table 127. Canine Arthritis Treatment: by Type(USD/Units)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Canine Arthritis Treatment: by Type(USD Million)
  • Table 138. Canine Arthritis Treatment Non-Steroidal Anti-Inflammatory Drugs , by Region USD Million (2023-2028)
  • Table 139. Canine Arthritis Treatment Opioids , by Region USD Million (2023-2028)
  • Table 140. Canine Arthritis Treatment Stem Cell Therapy , by Region USD Million (2023-2028)
  • Table 141. Canine Arthritis Treatment: by Application(USD Million)
  • Table 142. Canine Arthritis Treatment Veterinary Hospitals and Clinics , by Region USD Million (2023-2028)
  • Table 143. Canine Arthritis Treatment Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 144. Canine Arthritis Treatment Drug Stores , by Region USD Million (2023-2028)
  • Table 145. Canine Arthritis Treatment E-commerce , by Region USD Million (2023-2028)
  • Table 146. Canine Arthritis Treatment: by Route of Administration(USD Million)
  • Table 147. Canine Arthritis Treatment Oral , by Region USD Million (2023-2028)
  • Table 148. Canine Arthritis Treatment Parental , by Region USD Million (2023-2028)
  • Table 149. Canine Arthritis Treatment Others , by Region USD Million (2023-2028)
  • Table 150. Canine Arthritis Treatment: by Methods(USD Million)
  • Table 151. Canine Arthritis Treatment Surgery , by Region USD Million (2023-2028)
  • Table 152. Canine Arthritis Treatment Drugs , by Region USD Million (2023-2028)
  • Table 153. Canine Arthritis Treatment Others , by Region USD Million (2023-2028)
  • Table 154. South America Canine Arthritis Treatment, by Country USD Million (2023-2028)
  • Table 155. South America Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 156. South America Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 157. South America Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 158. South America Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 159. Brazil Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 160. Brazil Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 161. Brazil Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 162. Brazil Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 163. Argentina Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 164. Argentina Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 165. Argentina Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 166. Argentina Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 167. Rest of South America Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 168. Rest of South America Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 169. Rest of South America Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 170. Rest of South America Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 171. Asia Pacific Canine Arthritis Treatment, by Country USD Million (2023-2028)
  • Table 172. Asia Pacific Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 173. Asia Pacific Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 174. Asia Pacific Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 175. Asia Pacific Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 176. China Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 177. China Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 178. China Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 179. China Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 180. Japan Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 181. Japan Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 182. Japan Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 183. Japan Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 184. India Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 185. India Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 186. India Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 187. India Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 188. South Korea Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 189. South Korea Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 190. South Korea Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 191. South Korea Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 192. Taiwan Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 193. Taiwan Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 194. Taiwan Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 195. Taiwan Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 196. Australia Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 197. Australia Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 198. Australia Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 199. Australia Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 200. Rest of Asia-Pacific Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 201. Rest of Asia-Pacific Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 202. Rest of Asia-Pacific Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 203. Rest of Asia-Pacific Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 204. Europe Canine Arthritis Treatment, by Country USD Million (2023-2028)
  • Table 205. Europe Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 206. Europe Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 207. Europe Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 208. Europe Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 209. Germany Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 210. Germany Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 211. Germany Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 212. Germany Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 213. France Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 214. France Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 215. France Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 216. France Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 217. Italy Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 218. Italy Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 219. Italy Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 220. Italy Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 221. United Kingdom Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 222. United Kingdom Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 223. United Kingdom Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 224. United Kingdom Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 225. Netherlands Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 226. Netherlands Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 227. Netherlands Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 228. Netherlands Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 229. Rest of Europe Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 230. Rest of Europe Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 231. Rest of Europe Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 232. Rest of Europe Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 233. MEA Canine Arthritis Treatment, by Country USD Million (2023-2028)
  • Table 234. MEA Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 235. MEA Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 236. MEA Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 237. MEA Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 238. Middle East Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 239. Middle East Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 240. Middle East Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 241. Middle East Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 242. Africa Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 243. Africa Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 244. Africa Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 245. Africa Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 246. North America Canine Arthritis Treatment, by Country USD Million (2023-2028)
  • Table 247. North America Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 248. North America Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 249. North America Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 250. North America Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 251. United States Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 252. United States Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 253. United States Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 254. United States Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 255. Canada Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 256. Canada Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 257. Canada Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 258. Canada Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 259. Mexico Canine Arthritis Treatment, by Type USD Million (2023-2028)
  • Table 260. Mexico Canine Arthritis Treatment, by Application USD Million (2023-2028)
  • Table 261. Mexico Canine Arthritis Treatment, by Route of Administration USD Million (2023-2028)
  • Table 262. Mexico Canine Arthritis Treatment, by Methods USD Million (2023-2028)
  • Table 263. Canine Arthritis Treatment: by Type(USD/Units)
  • Table 264. Research Programs/Design for This Report
  • Table 265. Key Data Information from Secondary Sources
  • Table 266. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Canine Arthritis Treatment: by Type USD Million (2017-2022)
  • Figure 5. Global Canine Arthritis Treatment: by Application USD Million (2017-2022)
  • Figure 6. Global Canine Arthritis Treatment: by Route of Administration USD Million (2017-2022)
  • Figure 7. Global Canine Arthritis Treatment: by Methods USD Million (2017-2022)
  • Figure 8. South America Canine Arthritis Treatment Share (%), by Country
  • Figure 9. Asia Pacific Canine Arthritis Treatment Share (%), by Country
  • Figure 10. Europe Canine Arthritis Treatment Share (%), by Country
  • Figure 11. MEA Canine Arthritis Treatment Share (%), by Country
  • Figure 12. North America Canine Arthritis Treatment Share (%), by Country
  • Figure 13. Global Canine Arthritis Treatment: by Type USD/Units (2017-2022)
  • Figure 14. Global Canine Arthritis Treatment share by Players 2022 (%)
  • Figure 15. Global Canine Arthritis Treatment share by Players (Top 3) 2022(%)
  • Figure 16. Global Canine Arthritis Treatment share by Players (Top 5) 2022(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Nutri-Vet, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 19. Nutri-Vet, LLC (United States) Revenue: by Geography 2022
  • Figure 20. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Boehringer Ingelheim (Germany) Revenue: by Geography 2022
  • Figure 22. Liquid Health Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Liquid Health Inc. (United States) Revenue: by Geography 2022
  • Figure 24. American Regent, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. American Regent, Inc. (United States) Revenue: by Geography 2022
  • Figure 26. Matsun Nutrition (United States) Revenue, Net Income and Gross profit
  • Figure 27. Matsun Nutrition (United States) Revenue: by Geography 2022
  • Figure 28. Synflex America Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Synflex America Inc. (United States) Revenue: by Geography 2022
  • Figure 30. Thorne Research Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Thorne Research Inc. (United States) Revenue: by Geography 2022
  • Figure 32. Vetalogica (Australia) Revenue, Net Income and Gross profit
  • Figure 33. Vetalogica (Australia) Revenue: by Geography 2022
  • Figure 34. Elanco (United States) Revenue, Net Income and Gross profit
  • Figure 35. Elanco (United States) Revenue: by Geography 2022
  • Figure 36. Global Canine Arthritis Treatment: by Type USD Million (2023-2028)
  • Figure 37. Global Canine Arthritis Treatment: by Application USD Million (2023-2028)
  • Figure 38. Global Canine Arthritis Treatment: by Route of Administration USD Million (2023-2028)
  • Figure 39. Global Canine Arthritis Treatment: by Methods USD Million (2023-2028)
  • Figure 40. South America Canine Arthritis Treatment Share (%), by Country
  • Figure 41. Asia Pacific Canine Arthritis Treatment Share (%), by Country
  • Figure 42. Europe Canine Arthritis Treatment Share (%), by Country
  • Figure 43. MEA Canine Arthritis Treatment Share (%), by Country
  • Figure 44. North America Canine Arthritis Treatment Share (%), by Country
  • Figure 45. Global Canine Arthritis Treatment: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Nutri-Vet, LLC (United States)
  • Boehringer Ingelheim (Germany)
  • Liquid Health Inc. (United States)
  • American Regent, Inc. (United States)
  • Matsun Nutrition (United States)
  • Synflex America Inc. (United States)
  • Thorne Research Inc. (United States)
  • Vetalogica (Australia)
  • Elanco (United States)
Select User Access Type

Key Highlights of Report


May 2023 242 Pages 59 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Canine Arthritis Treatment Quantitative research analysis
Global Canine Arthritis Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Canine Arthritis Treatment Market are Nutri-Vet, LLC (United States), Boehringer Ingelheim (Germany), Liquid Health Inc. (United States), American Regent, Inc. (United States), Matsun Nutrition (United States), Synflex America Inc. (United States), Thorne Research Inc. (United States), Vetalogica (Australia) and Elanco (United States) etc.
Veterinary Hospitals and Clinics segment in Global market to hold robust market share owing to "High Prevalence of Canine Obesity and Motion Injuries ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Canine Arthritis Treatment market throughout the forecasted period.

Know More About Global Canine Arthritis Treatment Report?

Have a Query? Click Here

Other Related Reports

Infectious Disease Testing Comprehensive Study by Type (Assays, Kits, & Reagents, Instruments, Services and Software), Disease Type (Hepatitis, HIV, CT/NG, HAIs, HPV, TB, Influenza, Others), Technolo...
$ 3750
Insulin Lispro Comprehensive Study by Type (Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin), Application (Type 1 Diabetes, Type 2 Diabetes), Distribution...
$ 3450
Infertility Treatment Comprehensive Study by Application (Fertility Centers, Hospitals and Surgical Clinics, Research Institutes, Cryobanks), Equipment (Microscopes, Imaging Systems, Incubators, Sper...
$ 3750
Pediatric Interventional Cardiology Comprehensive Study by Type (Congenital Heart Defect Closure Devices (Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Foramen Ovale (PFO) C...
$ 3750
Animal Stem Cell Therapy Comprehensive Study by Type (Dogs, Cats, Horses, Others), Application (Osteoarthritis, Injuries to bones, Joints, Tendons, Ligament, Spinal cord, Others), Sources (Embryonic ...
$ 3650
Neuropathy Pain Treatment Comprehensive Study by Type (Peripheral Neuropathy, Entrapment Neuropathy, Post Traumatic Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Phantom Limb Pain,...
$ 3750